Porcine Pili Shield+CThis page contains information on Porcine Pili Shield+C for veterinary use.
The information provided typically includes the following:
- Porcine Pili Shield+C Indications
- Warnings and cautions for Porcine Pili Shield+C
- Direction and dosage information for Porcine Pili Shield+C
Porcine Pili Shield+CThis treatment applies to the following species:
Clostridium Perfringens Type C-Escherichia Coli Bacterin-Toxoid
For Use In Animals Only
Porcine Pili Shield+C Indications
For use in healthy pregnant swine as an aid in the control of disease in piglets caused by Clostridium perfringens Type C and K88, K99, 987P, and F41 piliated Escherichia coli.
ADJUVANT: Aluminum hydroxide.
Directions For Use
Shake well before using. Administer 2 mL intramuscularly at 5 and 2 weeks prior to farrowing. Revaccinate prior to each subsequent farrowing.
PrecautionsStore out of direct sunlight at 2°-7°C (35°-45°F). DO NOT FREEZE. Use entire contents when first opened. Do not vaccinate within 21 days prior to slaughter. It is essential that newborn pigs receive colostrum from the vaccinated dam. Anaphylactic reactions may occur. Symptomatic treatment: Epinephrine.
U.S. Vet. License No. 303; Novartis Animal Health US, Inc., Larchwood, IA 51241 USA; ©2010 Novartis; Pili Shield is a registered trademark of Novartis AG
NAC No.: 11140356
Farm Animal Business
1447 140TH ST., LARCHWOOD, IA, 51241
|Every effort has been made to ensure the accuracy of the Porcine Pili Shield+C information published above. However, it remains the responsibility of the readers to familiarize themselves with the product information contained on the US product label or package insert.|
Copyright © 2015 North American Compendiums. Updated: 2015-11-23